Literature DB >> 8374538

Recurrence of acute leukemia in donor cells after bone marrow transplantation: documentation by in situ DNA hybridization.

M Mouratidou1, D Sotiropoulos, K Deremitzaki, D H Spathas, A V Hoffbrand, H G Prentice, K Papanastasiou, S Tsakanikas, P Tsaftaridis, M Stamatelou.   

Abstract

Donor cell leukemia after BMT has been documented in a small number of cases mainly by cytogenetic studies. We describe a case of leukemia relapse in a 16-year-old girl 1 year after BMT from her histocompatible brother. Relapse in donor cells was initially suspected on the basis of cytogenetic analysis and confirmed by DNA in situ hybridization in blast cells using a Y chromosome-specific probe.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8374538

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  3 in total

1.  Early fulminant leukaemia post autologous bone marrow transplantation in non-Hodgkin's lymphoma patients.

Authors:  A Toren; G Rechavi; A Nagler
Journal:  Med Oncol       Date:  1998-07       Impact factor: 3.064

Review 2.  Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source.

Authors:  H Shiozaki; K Yoshinaga; T Kondo; Y Imai; M Shiseki; N Mori; M Teramura; T Motoji
Journal:  Bone Marrow Transplant       Date:  2013-09-09       Impact factor: 5.483

3.  Pediatric donor cell leukemia after allogeneic hematopoietic stem cell transplantation in AML patient from related donor.

Authors:  Lucina Bobadilla-Morales; Helia J Pimentel-Gutiérrez; Alfredo Corona-Rivera; Sergio Gallegos-Castorena; Jenny A Paniagua-Padilla; Citlalli Ortega-de-la-Torre; Fernando Sánchez-Zubieta; Rocio Silva-Cruz; Jorge R Corona-Rivera; Abraham Zepeda-Moreno; Oscar González-Ramella
Journal:  Mol Cytogenet       Date:  2015-01-31       Impact factor: 2.009
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.